Solvay SA Logo

Solvay SA

SOLB.BR

(2.5)
Stock Price

31,71 EUR

32.5% ROA

49.91% ROE

2.08x PER

Market Cap.

3.772.919.834,00 EUR

159.62% DER

6.76% Yield

26.02% NPM

Solvay SA Stock Analysis

Solvay SA Fundamental Analysis

Fundamental analysis in stock investing is like studying the foundation of a house before buying it. It involves looking at a company's financial health, like its earnings, assets, and debts, to determine if it's a good investment based on its fundamental strength and potential for growth.

Solvay SA Fundamental Stock Analysis
# Analysis Rating
1 PBV

The stock's low PBV ratio (1x) suggests it's undervalued, making it an attractive opportunity for investors.

2 DER

The stock has a low debt to equity ratio (26%), which means it has a small amount of debt compared to the ownership it holds

3 Dividend

Investors can take comfort in the company's unwavering commitment to dividends, as it has consistently distributed payouts over the past five years, ensuring a reliable income stream.

4 ROE

The stock's ROE falls within an average range (12%), demonstrating satisfactory profitability and efficiency in utilizing shareholders' equity.

5 ROA

The stock's ROA (9.07%) indicates that it's doing well in making money from the things it owns. This makes it a good option to invest and make consistent profits.

6 Graham Number

The Graham number of this company suggests that its stock price may be undervalued, indicating a potentially attractive investment opportunity.

7 Buffet Intrinsic Value

The company's stock seems undervalued (4.657) by Warren Buffett's formula, indicating a promising investment opportunity as its intrinsic value exceeds the market price.

8 Revenue Growth

Company has experienced no growth in revenue over the past three years, suggesting limited profitability and making it a less desirable investment opportunity.

9 Net Profit Growth

This company's net profit has remained stagnant over the past five years, indicating a lack of growth and making it a less favorable investment option.

10 Assets Growth

Company's revenue has stayed stagnant, showing no signs of improvement and making it a less favorable choice.

11 Dividend Growth

The company's dividend growth has remained unchanged for three years, signaling a lack of positive momentum and making it a less favorable investment choice.

Solvay SA Technical Analysis

Technical analysis in stock investing is like reading the patterns on a weather map to predict future weather conditions. It involves studying past stock price movements and trading volumes to make predictions about where a stock's price might go next, without necessarily looking at the company's financial health.

Solvay SA Technical Stock Analysis
# Analysis Recommendation
1 Awesome Oscillator Buy
2 MACD Buy
3 RSI Hold
4 Stoch RSI Sell

Solvay SA Price Chart

Financial Statements

Financial statements are like report cards for companies. They show how much money a company makes (income statement), what it owns and owes (balance sheet), and where it spends its money (cash flow statement), helping stock investors understand if a company is healthy and worth investing in.

Income Statements

An income statement for a company is like a scoreboard for its profits and losses. It shows how much money the company made (revenue) and how much it spent to make that money (expenses), helping stock investors see if a company is making a profit or not.

Revenue in stock investing is the total amount of money a company earns from its sales, and it's a key factor that investors consider to assess a company's financial performance and growth potential.

Solvay SA Revenue
Year Revenue Growth
2002 7.919.000.000
2003 7.557.000.000 -4.79%
2004 7.877.000.000 4.06%
2005 8.562.000.000 8%
2006 9.399.000.000 8.91%
2007 9.572.000.000 1.81%
2008 9.490.000.000 -0.86%
2009 8.485.000.000 -11.84%
2010 7.109.000.000 -19.36%
2011 8.109.000.000 12.33%
2012 12.830.000.000 36.8%
2013 10.367.000.000 -23.76%
2014 10.629.000.000 2.46%
2015 11.048.000.000 3.79%
2016 11.404.000.000 3.12%
2017 10.891.000.000 -4.71%
2018 11.299.000.000 3.61%
2019 11.227.000.000 -0.64%
2020 9.714.000.000 -15.58%
2021 11.435.000.000 15.05%
2022 16.071.000.000 28.85%
2023 12.132.000.000 -32.47%
2023 6.024.000.000 -101.39%
2024 5.332.000.000 -12.98%

Research and Development Expenses are the costs a company incurs to create and improve its products or services, which can be important for investors to evaluate a company's innovation and potential for future growth.

Solvay SA Research and Development Expenses
Year Research and Development Expenses Growth
2002 399.000.000
2003 404.000.000 1.24%
2004 413.000.000 2.18%
2005 472.000.000 12.5%
2006 563.000.000 16.16%
2007 556.000.000 -1.26%
2008 564.000.000 1.42%
2009 555.000.000 -1.62%
2010 181.000.000 -206.63%
2011 156.000.000 -16.03%
2012 261.000.000 40.23%
2013 237.000.000 -10.13%
2014 247.000.000 4.05%
2015 277.000.000 10.83%
2016 305.000.000 9.18%
2017 290.000.000 -5.17%
2018 297.000.000 2.36%
2019 323.000.000 8.05%
2020 300.000.000 -7.67%
2021 325.000.000 7.69%
2022 357.000.000 8.96%
2023 356.000.000 -0.28%
2023 35.000.000 -917.14%
2024 32.000.000 -9.38%

General and Administrative Expenses are the costs a company incurs to run its day-to-day operations, such as office rent, salaries, and utilities, which investors consider to understand a company's overall efficiency and management effectiveness.

Solvay SA General and Administrative Expenses
Year General and Administrative Expenses Growth
2002 1.412.000.000
2003 1.359.000.000 -3.9%
2004 1.320.000.000 -2.95%
2005 1.417.000.000 6.85%
2006 1.559.000.000 9.11%
2007 1.523.000.000 -2.36%
2008 1.567.000.000 2.81%
2009 1.482.000.000 -5.74%
2010 694.000.000 -113.54%
2011 660.000.000 -5.15%
2012 1.131.000.000 41.64%
2013 1.199.000.000 5.67%
2014 1.225.000.000 2.12%
2015 1.327.000.000 7.69%
2016 1.465.000.000 9.42%
2017 1.437.000.000 -1.95%
2018 1.006.000.000 -42.84%
2019 950.000.000 -5.89%
2020 900.000.000 -5.56%
2021 946.000.000 4.86%
2022 1.088.000.000 13.05%
2023 864.000.000 -25.93%
2023 426.000.000 -102.82%
2024 312.000.000 -36.54%

EBITDA stands for Earnings Before Interest, Taxes, Depreciation, and Amortization. It is a measure that helps stock investors analyze a company's profitability by looking at its earnings without considering certain expenses. This helps to get a clearer picture of the company's financial performance and its ability to generate cash flow.

Solvay SA EBITDA
Year EBITDA Growth
2002 1.221.000.000
2003 1.047.000.000 -16.62%
2004 1.205.000.000 13.11%
2005 1.019.000.000 -18.25%
2006 1.478.000.000 31.06%
2007 1.781.000.000 17.01%
2008 1.035.000.000 -72.08%
2009 1.148.000.000 9.84%
2010 3.015.000.000 61.92%
2011 1.156.000.000 -160.81%
2012 2.046.000.000 43.5%
2013 1.822.000.000 -12.29%
2014 1.749.000.000 -4.17%
2015 1.866.000.000 6.27%
2016 2.153.000.000 13.33%
2017 2.224.000.000 3.19%
2018 2.214.000.000 -0.45%
2019 2.332.000.000 5.06%
2020 1.928.000.000 -20.95%
2021 2.289.000.000 15.77%
2022 3.267.000.000 29.94%
2023 2.512.000.000 -30.06%
2023 1.127.000.000 -122.89%
2024 1.184.000.000 4.81%

Gross profit is the money a company makes from selling its products or services after subtracting the cost of producing or providing them, and it is an important measure for investors to understand a company's profitability.

Solvay SA Gross Profit
Year Gross Profit Growth
2002 2.679.000.000
2003 2.456.000.000 -9.08%
2004 2.604.000.000 5.68%
2005 2.838.000.000 8.25%
2006 3.273.000.000 13.29%
2007 3.330.000.000 1.71%
2008 3.109.000.000 -7.11%
2009 2.990.000.000 -3.98%
2010 1.523.000.000 -96.32%
2011 1.564.000.000 2.62%
2012 2.560.000.000 38.91%
2013 2.324.000.000 -10.15%
2014 2.559.000.000 9.18%
2015 2.759.000.000 7.25%
2016 3.090.000.000 10.71%
2017 3.086.000.000 -0.13%
2018 3.035.000.000 -1.68%
2019 2.983.000.000 -1.74%
2020 2.507.000.000 -18.99%
2021 2.927.000.000 14.35%
2022 4.029.000.000 27.35%
2023 3.604.000.000 -11.79%
2023 1.323.000.000 -172.41%
2024 1.236.000.000 -7.04%

Net income in stock investing is like the money a company actually gets to keep as profit after paying all its bills, and it's an important measure to understand how well a company is doing financially.

Solvay SA Net Profit
Year Net Profit Growth
2002 494.000.000
2003 430.000.000 -14.88%
2004 541.000.000 20.52%
2005 816.000.000 33.7%
2006 817.000.000 0.12%
2007 828.000.000 1.33%
2008 449.000.000 -84.41%
2009 553.000.000 18.81%
2010 1.823.000.000 69.67%
2011 297.000.000 -513.8%
2012 584.000.000 49.14%
2013 270.000.000 -116.3%
2014 80.000.000 -237.5%
2015 406.000.000 80.3%
2016 621.000.000 34.62%
2017 1.061.000.000 41.47%
2018 858.000.000 -23.66%
2019 -79.000.000 1186.08%
2020 -1.092.000.000 92.77%
2021 948.000.000 215.19%
2022 1.905.000.000 50.24%
2023 880.000.000 -116.48%
2023 2.093.000.000 57.96%
2024 268.000.000 -680.97%

EPS, or earnings per share, is a measure that shows how much profit a company has earned for each outstanding share of its stock, and it is important for stock investors as it helps understand the profitability of a company and compare it with other companies in the market.

Solvay SA Earning per Share (EPS)
Year Earning per Share (EPS) Growth
2002 5
2003 4 -25%
2004 6 20%
2005 9 37.5%
2006 9 0%
2007 9 0%
2008 5 -100%
2009 6 20%
2010 21 75%
2011 3 -900%
2012 6 66.67%
2013 3 -100%
2014 1 0%
2015 5 100%
2016 6 33.33%
2017 10 40%
2018 8 -25%
2019 -1 0%
2020 -11 100%
2021 9 211.11%
2022 18 50%
2023 8 -125%
2023 20 60%
2024 3 -900%

Cashflow Statements

Cashflow statements show the movement of money in and out of a company, helping stock investors understand how much money a company makes and spends. By examining cashflow statements, investors can assess if a company is generating enough cash to pay its bills, invest in growth, and provide returns to stockholders.

Free cash flow is the leftover cash that a company generates after covering its operating expenses and capital expenditures, which is important for stock investors as it shows how much money a company has available to invest in growth, pay dividends, or reduce debt.

Solvay SA Free Cashflow
Year Free Cashflow Growth
2002 848.000.000
2003 870.000.000 2.53%
2004 539.000.000 -61.41%
2005 464.000.000 -16.16%
2006 557.000.000 16.7%
2007 419.000.000 -32.94%
2008 530.000.000 20.94%
2009 728.000.000 27.2%
2010 331.000.000 -119.94%
2011 192.000.000 -72.4%
2012 672.000.000 71.43%
2013 468.000.000 -43.59%
2014 634.000.000 26.18%
2015 351.000.000 -80.63%
2016 807.000.000 56.51%
2017 782.000.000 -3.2%
2018 887.000.000 11.84%
2019 958.000.000 7.41%
2020 707.000.000 -35.5%
2021 863.000.000 18.08%
2022 1.097.000.000 21.33%
2023 338.000.000 -224.56%
2023 810.000.000 58.27%
2024 109.000.000 -643.12%

Operating cash flow represents the cash generated or consumed by a company's day-to-day operations, excluding external investing or financing activities, and is crucial for stock investors as it shows how much cash a company is generating from its core business operations.

Solvay SA Operating Cashflow
Year Operating Cashflow Growth
2002 848.000.000
2003 870.000.000 2.53%
2004 970.000.000 10.31%
2005 969.000.000 -0.1%
2006 1.138.000.000 14.85%
2007 852.000.000 -33.57%
2008 1.277.000.000 33.28%
2009 1.184.000.000 -7.85%
2010 697.000.000 -69.87%
2011 794.000.000 12.22%
2012 1.457.000.000 45.5%
2013 1.278.000.000 -14.01%
2014 1.621.000.000 21.16%
2015 1.388.000.000 -16.79%
2016 1.788.000.000 22.37%
2017 1.604.000.000 -11.47%
2018 1.720.000.000 6.74%
2019 1.815.000.000 5.23%
2020 1.242.000.000 -46.14%
2021 1.499.000.000 17.14%
2022 2.006.000.000 25.27%
2023 625.000.000 -220.96%
2023 1.874.000.000 66.65%
2024 142.000.000 -1219.72%

Capex, short for capital expenditures, refers to the money a company spends on acquiring or upgrading tangible assets like buildings, equipment, or technology, which is important for stock investors as it indicates how much a company is investing in its infrastructure to support future growth and profitability.

Solvay SA Capital Expenditure
Year Capital Expenditure Growth
2002 0
2003 0 0%
2004 431.000.000 100%
2005 505.000.000 14.65%
2006 581.000.000 13.08%
2007 433.000.000 -34.18%
2008 747.000.000 42.03%
2009 456.000.000 -63.82%
2010 366.000.000 -24.59%
2011 602.000.000 39.2%
2012 785.000.000 23.31%
2013 810.000.000 3.09%
2014 987.000.000 17.93%
2015 1.037.000.000 4.82%
2016 981.000.000 -5.71%
2017 822.000.000 -19.34%
2018 833.000.000 1.32%
2019 857.000.000 2.8%
2020 535.000.000 -60.19%
2021 636.000.000 15.88%
2022 909.000.000 30.03%
2023 287.000.000 -216.72%
2023 1.064.000.000 73.03%
2024 33.000.000 -3124.24%

Balance Sheet

Balance sheets provide a snapshot of a company's financial health and its assets (such as cash, inventory, and property) and liabilities (like debts and obligations) at a specific point in time. For stock investors, balance sheets help assess the company's overall worth and evaluate its ability to meet financial obligations and support future growth.

Equity refers to the ownership interest or stake that shareholders have in a company, representing their claim on its assets and earnings after all debts and liabilities are paid.

Solvay SA Equity
Year Equity Growth
2002 2.686.000.000
2003 2.666.000.000 -0.75%
2004 2.882.000.000 7.49%
2005 3.774.000.000 23.64%
2006 4.214.000.000 10.44%
2007 4.459.000.000 5.49%
2008 4.449.000.000 -0.22%
2009 5.160.000.000 13.78%
2010 6.839.000.000 24.55%
2011 6.653.000.000 -2.8%
2012 6.597.000.000 -0.85%
2013 7.452.000.000 11.47%
2014 6.778.000.000 -9.94%
2015 9.668.000.000 29.89%
2016 9.957.000.000 2.9%
2017 9.754.000.000 -2.08%
2018 10.626.000.000 8.21%
2019 9.624.000.000 -10.41%
2020 7.303.000.000 -31.78%
2021 8.851.000.000 17.49%
2022 10.664.000.000 17%
2023 1.305.000.000 -717.16%
2023 10.625.000.000 87.72%
2024 1.421.000.000 -647.71%

Assets represent the valuable resources that a company owns, such as cash, inventory, property, and equipment, and understanding a company's assets helps investors assess its value and potential for generating future profits.

Solvay SA Assets
Year Assets Growth
2002 9.464.000.000
2003 9.687.000.000 2.3%
2004 10.037.000.000 3.49%
2005 11.240.000.000 10.7%
2006 11.101.000.000 -1.25%
2007 11.180.000.000 0.71%
2008 12.264.000.000 8.84%
2009 12.546.000.000 2.25%
2010 14.014.000.000 10.48%
2011 19.437.000.000 27.9%
2012 18.328.000.000 -6.05%
2013 18.433.000.000 0.57%
2014 17.894.000.000 -3.01%
2015 25.329.000.000 29.35%
2016 24.145.000.000 -4.9%
2017 21.451.000.000 -12.56%
2018 22.000.000.000 2.5%
2019 21.307.000.000 -3.25%
2020 16.792.000.000 -26.89%
2021 20.049.000.000 16.25%
2022 20.661.000.000 2.96%
2023 7.022.000.000 -194.23%
2023 19.921.000.000 64.75%
2024 6.614.000.000 -201.19%

Liabilities refer to the financial obligations or debts that a company owes to creditors or external parties, and understanding a company's liabilities is important for investors as it helps assess the company's financial risk and ability to meet its obligations.

Solvay SA Liabilities
Year Liabilities Growth
2002 5.900.000.000
2003 6.155.000.000 4.14%
2004 6.245.000.000 1.44%
2005 7.320.000.000 14.69%
2006 6.645.000.000 -10.16%
2007 6.721.000.000 1.13%
2008 7.519.000.000 10.61%
2009 7.386.000.000 -1.8%
2010 7.175.000.000 -2.94%
2011 12.784.000.000 43.88%
2012 11.731.000.000 -8.98%
2013 10.981.000.000 -6.83%
2014 11.116.000.000 1.21%
2015 15.661.000.000 29.02%
2016 14.188.000.000 -10.38%
2017 11.697.000.000 -21.3%
2018 11.374.000.000 -2.84%
2019 11.683.000.000 2.64%
2020 9.489.000.000 -23.12%
2021 11.198.000.000 15.26%
2022 9.997.000.000 -12.01%
2023 5.717.000.000 -74.86%
2023 9.296.000.000 38.5%
2024 5.193.000.000 -79.01%

Solvay SA Financial Ratio (TTM)

Valuation Metrics

Revenue per Share
66.42
Net Income per Share
17.29
Price to Earning Ratio
2.08x
Price To Sales Ratio
0.54x
POCF Ratio
3.71
PFCF Ratio
11.72
Price to Book Ratio
2.79
EV to Sales
0.78
EV Over EBITDA
3.69
EV to Operating CashFlow
5.35
EV to FreeCashFlow
16.95
Earnings Yield
0.48
FreeCashFlow Yield
0.09
Market Cap
3,77 Bil.
Enterprise Value
5,46 Bil.
Graham Number
70.74
Graham NetNet
-32.39

Income Statement Metrics

Net Income per Share
17.29
Income Quality
7.4
ROE
0.5
Return On Assets
0.28
Return On Capital Employed
0.18
Net Income per EBT
4.52
EBT Per Ebit
0.45
Ebit per Revenue
0.13
Effective Tax Rate
0.73

Margins

Sales, General, & Administrative to Revenue
0.01
Research & Developement to Revenue
0.02
Stock Based Compensation to Revenue
0
Gross Profit Margin
0.25
Operating Profit Margin
0.13
Pretax Profit Margin
0.06
Net Profit Margin
0.26

Dividends

Dividend Yield
0.07
Dividend Yield %
6.76
Payout Ratio
0.15
Dividend Per Share
2.43

Operating Metrics

Operating Cashflow per Share
9.68
Free CashFlow per Share
3.05
Capex to Operating CashFlow
0.68
Capex to Revenue
0.1
Capex to Depreciation
1.18
Return on Invested Capital
0.07
Return on Tangible Assets
0.32
Days Sales Outstanding
63.73
Days Payables Outstanding
52.51
Days of Inventory on Hand
41.09
Receivables Turnover
5.73
Payables Turnover
6.95
Inventory Turnover
8.88
Capex per Share
6.63

Balance Sheet

Cash per Share
5,36
Book Value per Share
13,47
Tangible Book Value per Share
3.95
Shareholders Equity per Share
12.87
Interest Debt per Share
21.7
Debt to Equity
1.6
Debt to Assets
0.33
Net Debt to EBITDA
1.14
Current Ratio
1.37
Tangible Asset Value
0,42 Bil.
Net Current Asset Value
-2,82 Bil.
Invested Capital
4002000000
Working Capital
0,65 Bil.
Intangibles to Total Assets
0.15
Average Receivables
1,23 Bil.
Average Payables
0,77 Bil.
Average Inventory
613000000
Debt to Market Cap
0.57

Dividends

Dividends in stock investing are like rewards that companies give to their shareholders. They are a portion of the company's profits distributed to investors, typically in the form of cash payments, as a way for them to share in the company's success.

Solvay SA Dividends
Year Dividends Growth
2002 3
2003 3 0%
2004 2 0%
2005 3 0%
2006 3 33.33%
2007 3 -50%
2008 3 0%
2009 3 0%
2010 3 0%
2011 3 33.33%
2012 3 0%
2013 3 0%
2014 3 0%
2015 3 0%
2016 3 0%
2017 3 0%
2018 4 0%
2019 4 0%
2020 4 0%
2021 4 0%
2022 6 50%
2023 4 -50%
2024 2 -100%

Solvay SA Profile

About Solvay SA

Solvay SA provides advanced materials and specialty chemicals worldwide. It operates through four segments: Materials, Chemicals, Solutions, and Corporate & Business Services. The Materials segment offers specialty polymers, including aromatic polymers, high barrier polymers, and fluoropolymers for the electronics, automotive, aircraft, and healthcare industries; and composite materials for aerospace engineered materials market. The Chemicals segment produces and sells soda ash and sodium bicarbonate primarily to the flat and container glass industries, as well as for use in detergents, pharmaceutical, and feed and food industries; hydrogen peroxide for use primarily in the paper industry to bleach pulp, as well as chemicals, electronics, food, mining, and environment; and dispersible silica for tire manufacturers; and solvent solutions, specialty phenols, polyamide derivatives and smart, functional, and sustainable yarns and polymers. The Solutions segment offers specialty chemicals for agro, home and personal care, coatings, and industrial markets; technology solutions in specialty mining reagents, phosphine-based chemistry, and solutions for the stabilization of polymers; fluorine and rare-earth formulations for automotive, electronics, agrochemical, and construction applications; and vanillin for the flavors and fragrances industries, as well as synthetic intermediates used in pharmaceuticals, agrochemicals, and electronics. This segment also provides friction reducers, gelling agents, emulsion breakers, surfactants, inhibitors, cementing additives, and biocides for upstream oilfield chemicals sector, as well as sodium hypophosphite for metal plating and other applications. The Corporate & Business Services segment provides energy and other business services. The company was founded in 1863 and is headquartered in Brussels, Belgium.

CEO
Mr. Philippe Kehren
Employee
9.000
Address
Rue de Ransbeek, 310
Brussels, 1120

Solvay SA Executives & BODs

Solvay SA Executives & BODs
# Name Age
1 Dr. Mark Van Bijsterveld
Chief People Officer & Member of Executive Committee
70
2 Mr. Alexandre Blum
Chief Financial and Strategy Officer & Member of Executive Committee
70
3 Mr. Lanny Duvall
Chief Operating Officer & Member of Executive Committee
70
4 Mr. Michael Finelli
Chief Technology Officer
70
5 Mr. Vincent Kamel
President of Performance Polyamides
70
6 Mr. J. Michael Radossich
President of Novecare Business
70
7 Mr. Carlos Silveira
President of Peroxides GBU
70
8 Ms. An Nuyttens
President of Aroma Performance & Silica Businesses
70
9 Mr. Philippe Kehren
Chief Executive Officer, Chairman of Executive Committee & Director
70
10 Ms. Lisa Jane Brown
General Counsel, Corporate Secretary & Member of Executive Committee
70

Solvay SA Competitors